Effect of universal WBC reduction [3] (multiple letters)

Transfusion

Volumn 43, Issue 6, 2003, Pages 831-833

  Wenz, Barry ^f   Ortolano, Girolamo A ^a   Dzik, Walter H ^b   Anderson, Joy K ^c   O'Neill, E Mary ^d   Assmann, Susan F ^e   Kalish, Leslie A ^e   Stowell, Christopher P ^b  

^a PALL CORPORATION   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Anagen Therapeutics Inc   (United States)

^d AMERICAN RED CROSS BLOOD SERVICES   (United States)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; FORMALDEHYDE;

APHERESIS; BLOOD TRANSFUSION; CELL SEPARATION; CONCENTRATION (PARAMETERS); COST BENEFIT ANALYSIS; HEALTH CARE COST; HUMAN; INFECTION RATE; LETTER; LEUKOCYTE; MONONUCLEAR CELL; PRACTICE GUIDELINE; RANDOMIZATION; STAPHYLOCOCCUS AUREUS; THROMBOCYTE;

EID: 0037674665     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00411.x     Document Type: Letter

References (0)